Medicare part D enrollees' use of out-of-plan discounted generic drugs

Journal of the American Geriatrics Society

Volumn 60, Issue 2, 2012, Pages 387-388

  Stuart, Bruce ^a   Loh, Ellen F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIRHEUMATIC AGENT; CARDIAC AGENT; GASTROINTESTINAL AGENT; GENERIC DRUG; PRESCRIPTION DRUG; VITAMIN;

ADVISORY COMMITTEE; COST CONTROL; DRUG COST; ELDERLY CARE; HUMAN; LETTER; MEDICARE; MEDICATION THERAPY MANAGEMENT;

DRUGS, GENERIC; HUMANS; MEDICARE PART D; UNITED STATES;

EID: 84856921241     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03812.x     Document Type: Letter

References (3)

1. Zhang Y, Zhou L, Gellad WF,. Potential savings from greater use of $4 generic drugs. Arch Intern Med 2011; 171: 468-469.
2. Medicare Payment Advisory Commission. Report to Congress: Medicare Payment Policy. March 2011. Washington DC: Medicare Payment Advisory Commission.
3. The 2012 Humana Walmart-Preferred Rx Plan (PDP) [on-line]. Available at Accessed August 26, 2011.